CA2666177A1 - Acylaminoimidazoles and acylaminothiazoles - Google Patents
Acylaminoimidazoles and acylaminothiazoles Download PDFInfo
- Publication number
- CA2666177A1 CA2666177A1 CA002666177A CA2666177A CA2666177A1 CA 2666177 A1 CA2666177 A1 CA 2666177A1 CA 002666177 A CA002666177 A CA 002666177A CA 2666177 A CA2666177 A CA 2666177A CA 2666177 A1 CA2666177 A1 CA 2666177A1
- Authority
- CA
- Canada
- Prior art keywords
- alkyl
- substituents
- another
- substituted
- group
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/88—Nitrogen atoms, e.g. allantoin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE102006048042.2 | 2006-10-11 | ||
| DE102006048042A DE102006048042A1 (de) | 2006-10-11 | 2006-10-11 | Acylaminoimidazole und Acylaminothiazole |
| PCT/EP2007/008789 WO2008043533A2 (de) | 2006-10-11 | 2007-10-10 | Acylaminoimidazole und acylaminothiazole |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA2666177A1 true CA2666177A1 (en) | 2008-04-17 |
Family
ID=39184814
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002666177A Abandoned CA2666177A1 (en) | 2006-10-11 | 2007-10-10 | Acylaminoimidazoles and acylaminothiazoles |
Country Status (5)
| Country | Link |
|---|---|
| EP (1) | EP2079708A2 (de) |
| JP (1) | JP2010505896A (de) |
| CA (1) | CA2666177A1 (de) |
| DE (1) | DE102006048042A1 (de) |
| WO (1) | WO2008043533A2 (de) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2350002A1 (de) * | 2008-10-02 | 2011-08-03 | Abbott Laboratories | Neue verbindungen als kalziumkanalblocker |
| WO2011115813A1 (en) | 2010-03-18 | 2011-09-22 | Abbott Laboratories | Lactam acetamides as calcium channel blockers |
| JP2015083542A (ja) * | 2012-02-08 | 2015-04-30 | 大日本住友製薬株式会社 | ３位置換プロリン誘導体 |
| IN2014MU00072A (de) * | 2014-01-08 | 2015-08-21 | Wockhardt Ltd | |
| IL277071B1 (en) | 2018-03-08 | 2024-03-01 | Incyte Corp | Aminopyrizine diol compounds as PI3K–y inhibitors |
| US11046658B2 (en) | 2018-07-02 | 2021-06-29 | Incyte Corporation | Aminopyrazine derivatives as PI3K-γ inhibitors |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2842523A1 (fr) * | 2002-07-17 | 2004-01-23 | Sanofi Synthelabo | Derives d'acylaminothiazole, leur preparation et leur application en therapeutique |
| RS50595B (sr) * | 2004-03-23 | 2010-05-07 | Pfizer Products Incorporated | Jedinjenja imidazola za lečenje neurodegenerativnih poremećaja |
| DE102006001574A1 (de) * | 2006-01-12 | 2007-07-19 | Bayer Healthcare Ag | Acylaminoimidazole |
-
2006
- 2006-10-11 DE DE102006048042A patent/DE102006048042A1/de not_active Withdrawn
-
2007
- 2007-10-10 WO PCT/EP2007/008789 patent/WO2008043533A2/de active Application Filing
- 2007-10-10 JP JP2009531766A patent/JP2010505896A/ja active Pending
- 2007-10-10 CA CA002666177A patent/CA2666177A1/en not_active Abandoned
- 2007-10-10 EP EP07818862A patent/EP2079708A2/de not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| WO2008043533A2 (de) | 2008-04-17 |
| DE102006048042A1 (de) | 2008-04-17 |
| WO2008043533A3 (de) | 2008-07-03 |
| EP2079708A2 (de) | 2009-07-22 |
| JP2010505896A (ja) | 2010-02-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2660421C2 (ru) | Бензиламиновые производные | |
| JP4598771B2 (ja) | 複素環式化合物 | |
| US20100105663A1 (en) | 2-(heteroaryl) alkyl indazole 6-phenyl and thienyl methyl amide as thrombin inhibitors | |
| CA2666401A1 (en) | Acylaminopyrazoles for treating cardiovascular diseases | |
| CA2666177A1 (en) | Acylaminoimidazoles and acylaminothiazoles | |
| RU2605600C2 (ru) | Амино-замещенные производные 3-гетероароиламинопропионовой кислоты и их применение в качестве фармацевтических средств | |
| CA2653666C (en) | Aryl-substituted heterocycles and their use | |
| US20160244437A1 (en) | Substituted phenylalanine derivatives | |
| KR20160064100A (ko) | 치환된 페닐알라닌 유도체 | |
| US20160237067A1 (en) | Substituted phenylalanine derivatives | |
| JP2009507055A (ja) | イミノオキサゾリジン誘導体およびその使用 | |
| HUT76484A (en) | Novel tetrasubstituted imidazole derivatives, method for preparing same, and pharmaceutical compositions containing same | |
| EP2173744A1 (de) | Substituierte (oxazolidinon-5-yl-methyl) -2-thiophen-carboxamide und ihre verwendung im gebiet der blutgerinnung | |
| TWI740903B (zh) | 新穎吡咯啶衍生物 | |
| WO2007140982A1 (de) | Substituierte benzoxazole | |
| CA2653665A1 (en) | Isoindolin-1-one, isoindolin-3-one and isoindoline-1,3-dione-derivatives and their use | |
| WO2007082666A1 (de) | Acylaminoimidazole | |
| CA2653673A1 (en) | Isoindolin-1-one, isoindolin-3-one and isoindoline-1,3-dione derivatives and their use | |
| CA2653670A1 (en) | Substituted heterocycles and their use |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FZDE | Dead |